Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study

First line treatment for Parkinson’s disease (PD) is typically either L-dopa or a non-ergot dopamine agonist (DA). However, the options for the treatment of motor symptoms in PD patients have increased in the last thirty years, which have seen several new classes of PD medications introduced onto th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Saudi Pharm J
Autors principals: Orayj, Khalid, Akbari, Ashley, Lacey, Arron, Smith, Mathew, Pickrell, Owen, Lane, Emma L.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910137/
https://ncbi.nlm.nih.gov/pubmed/33679182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2021.01.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars